Medreich Limited Flucloxacillin Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Flucloxacillin Export Records India — #1 Exporter, 337 Shipments, $16.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Flucloxacillin

India Pharmaceutical Trade Intelligence

$38.8M123 Suppliers44 CountriesHS 30041090

ExportsIndia → UNITED KINGDOM36.4%India → AUSTRALIA14.0%

ImportsAUSTRALIA → India$10.0K UNITED KINGDOM → India$8.9K

#1 Supplier: MEDREICH LIMITED #1 Buyer: MEDREICH PLC

Medreich Limited — Flucloxacillin Exporter #1 | $16.9M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Flucloxacillin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Flucloxacillin · $16.9M export value · DGFT Verified

Medreich Limited is the #1 Indian exporter of Flucloxacillin with $16.9M in export value and 337 verified shipments. Medreich Limited holds a 43.4% market share in Flucloxacillin exports across 8 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Flucloxacillin Export Profile: Buyers & Destinations

Medreich Limited Flucloxacillin export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Flucloxacillin?

Country	Value	Shipments	Share
UNITED KINGDOM	$5.7M	157	48.5%
AUSTRALIA	$2.9M	73	24.4%
NETHERLANDS	$2.5M	84	21.3%
SOUTH AFRICA	$469.4K	17

Who Are the Top Buyers of Flucloxacillin from Medreich Limited?

Buyer	Country	Value	Orders
MEDREICH PLC	UNITED KINGDOM	$5.7M	157
MYLAN AUSTRALIA PTY LIMITED	AUSTRALIA	$2.9M	73
MYLAN IRELAND LTD	NETHERLANDS	$1.2M	48
MYLAN B.V	NETHERLANDS	$626.3K	21
MYLAN BV	NETHERLANDS	$350.0K	7
OETHMAAN BIOSIMS PTY LTD	SOUTH AFRICA	$272.1K	8
MYLAN B V ALLOGA NETHERLANDS BVDE KEMPKENS	NETHERLANDS	$257.1K	6
SANDOZ SA (PTY) LTD	SOUTH AFRICA	$120.8K	4
MYLAN B V	NETHERLANDS	$100.0K	2
VIATRIS NEW ZEALAND	NEW ZEALAND	$100.0K	2

Medreich Limited supplies Flucloxacillin to 16 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by MYLAN AUSTRALIA PTY LIMITED (AUSTRALIA) and MYLAN IRELAND LTD (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Flucloxacillin Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
FLUCLOXACILLIN 500MG CAPSULES BP 2X14S	$569.8K	14
FLUCLOXACILLIN 500MG CAPSULES BP 2X14	$406.8K	10
FLUCLOXACILLIN CAPSULES BP 500MG 2X14S	$374.7K	10
FLUCLOXACILLIN CAPSULES 500MG (STAPHLEX	$300.0K	6
FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:30S QTY:12860	$300.0K	6
FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:75S QTY:5154	$300.0K	6
FLUCLOXACILLIN CAPSULES 500MG STAPHYLEX	$250.0K	5
FLUCLOXACILLIN 500MG CAPSULES BP (PACK S	$200.0K	4
FLUCLOXACILLIN FC TABLETS 1G(HERACILLIN1G) PACK SIZE:21S QTY:9223	$174.7K	6
FLUCLOXACILLIN CAPSULES BP 500MG 2X14	$174.2K	4

Medreich Limited exports 171 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUCLOXACILLIN 500MG CAPSULES BP 2X14S with 14 shipments worth $569.8K.

How Does Medreich Limited Compare to Nearest Flucloxacillin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MEDREICH LIMITED ★	$16.9M	337	8	$50.0K
2	MICRO LABS LIMITED	$4.0M	81	2	$50.0K
5	AUROBINDO PHARMA LTD	$1.7M	43	1	$39.3K

Medreich Limited ranks #1 among 123 Indian Flucloxacillin exporters. Average shipment value of $50.0K compared to the market average of $243.5K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Flucloxacillin Exports?

Port	Shipments	% Share
BANGALORE ICD	140	12.2%
BANGALORE ICD (INWFD6)	107	9.3%
NHAVA SHEVA SEA (INNSA1)	100	8.7%
JNPT	76	6.6%
BANGALORE ACC (INBLR4)	69	6.0%
JNPT/ NHAVA SHEVA SEA	55	4.8%
SAHAR AIR	50	4.4%
BANGALORE AIR	36	3.1%

Geopolitical & Trade Policy Impact on Medreich Limited's Flucloxacillin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 337 individual customs records matching Medreich Limited exporting Flucloxacillin, covering 171 formulations to 8 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 198+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Flucloxacillin

Flucloxacillin

Medreich Limited — Flucloxacillin Exporter Profile

Medreich Limited — Flucloxacillin Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Flucloxacillin?

Who Are the Top Buyers of Flucloxacillin from Medreich Limited?

What Is India's Total Flucloxacillin Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Flucloxacillin Exports?

How Does Medreich Limited Compare to Other Indian Flucloxacillin Exporters?

What Flucloxacillin Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Flucloxacillin to Key Markets

United Kingdom — MHRA

Australia — TGA

How Does Medreich Limited Compare to Nearest Flucloxacillin Exporters?

Which Indian Ports Ship Flucloxacillin Exports?

What Other Advanced Antibiotics Products Does Medreich Limited Export?

Geopolitical & Trade Policy Impact on Medreich Limited's Flucloxacillin Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Flucloxacillin Export Data from Medreich Limited

Flucloxacillin Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source